Skip to main content
. Author manuscript; available in PMC: 2017 Oct 1.
Published in final edited form as: Anticancer Res. 2016 Oct;36(10):5307–5314. doi: 10.21873/anticanres.11103

Figure 1.

Figure 1

Kaplan-Meier analysis for adiponectin and overall survival among 135 hepatocellular carcinoma (HCC) patients without liver transplantation. Dashed line indicates plasma adiponectin levels ≥Median, while solid line means adiponectin <Median. The Kaplan-Meier analysis showed that HCC patients with higher adiponectin may be more likely to experience a worse overall survival (HR=1.72, 95%CI=1.12–2.64, p=0.014).